Skip to Content

WATSON 583 (Propafenone Hydrochloride 225 MG)

Pill with imprint WATSON 583 is White, Round and has been identified as Propafenone Hydrochloride 225 MG. It is supplied by Watson Laboratories, Inc..

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; wolff-parkinson-white syndrome; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 MG is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 583

Propafenone hydrochloride 225 MG WATSON 583
Propafenone hydrochloride 225 MG WATSON 583  Front
Propafenone hydrochloride 225 MG WATSON 583  Back
Propafenone hydrochloride 225 MG WATSON 583

Propafenone Hydrochloride

Imprint
WATSON 583
Strength
225 MG
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, crospovidone, hypromelloses, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, corn starch, sodium lauryl sulfate, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-0583 Watson Pharmaceuticals, Inc.
63739-0510 McKesson Packaging Services
54569-6133 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.